A Method for the Acute and Rapid Degradation of Endogenous Proteins.
Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M. · 2017
Read A Method for the Acute and Rapid Degradation of Endogenous Proteins. by Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5733393.txt.
Introduction
Clift and co-authors present Trim-Away, a fast way to destroy a chosen protein inside cells. Gene knockout and RNA methods act slowly, through DNA or RNA. Long lived proteins can resist both for days. Cells also gain time to mask the loss.
Trim-Away uses antibodies to tag the target protein where it sits. A cell receptor, TRIM21, then sends the tagged protein for breakdown. Removal takes minutes, with no change to the genome. The method works in many cell types, even cells that no longer divide. Ready made antibodies make it usable for a wide range of targets.
Catalog record
| CREATOR | Clift D, McEwan WA, Labzin LI, Konieczny V, Mogessie B, James LC, Schuh M. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 96 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
A Method for the Acute and Rapid Degradation of Endogenous Proteins By Dean Clift, William A McEwan, Larisa I Labzin, Vera Konieczny, Binyam Mogessie, Leo C James, Melina Schuh Published in: Cell DOI: 10.1016/j.cell.2017.10.033 ABSTRACT Summary Methods for the targeted disruption of protein function have revolutionized science and greatly expedited the systematic characterization of genes. Two main approaches are currently used to disrupt protein function: DNA knockout and RNA interference, which act at the genome and mRNA level, respectively. A method that directly alters endogenous protein levels is currently not available. Here, we present Trim-Away, a technique to degrade endogenous proteins acutely in mammalian cells without prior modification of the genome or mRNA. Trim-Away harnesses the cellular protein degradation machinery to remove unmodified native proteins within minutes of application. This rapidity minimizes the risk that phenotypes are compensated and that secondary, non-specific defects accumulate over time. Because Trim-Away utilizes antibodies, it can be applied to a wide range of target proteins using off-the-shelf reagents. Trim-Away allows the study of protein function in diverse cell types, including non-dividing primary cells where genome- and RNA-targeting methods are limited. Keywords: protein degradation, protein knockdown, cell division, meiosis, primary cells, oocytes, macrophages, antibodies, RNAi, CRISPR/Cas9 INTRODUCTION Interfering with protein expression is a powerful strategy to investigate the function of a protein. Traditionally, DNA-modifying methods have been used to knockout proteins on the gene level (Capecchi, 1989), an approach that has had a recent resurgence with the emergence of CRISPR/Cas9 technology (Doudna and Charpentier, 2014). RNA-targeting methods such as RNAi are also widely used to knockdown expression of a protein by destroying the mRNA (Elbashir et al., 2001). However, in both approaches, protein depletion is indirect and dependent on the inherent turnover of the protein. Consequently, long-lived proteins take more time to deplete, or may be resistant to DNA- and RNA-targeting depletion methods altogether (Jansen et al., 2007, Smoak et al., 2016). The long time frame that is required for protein depletion with these methods also means that cells may have enough time to activate compensatory mechanisms, which may mask phenotypes (Damke et al., 1995, Rossi et al., 2015). Furthermore, it is often impossible to determine whether or not a phenotype is an indirect consequence of an earlier defect. In an attempt to overcome these problems, several methods have been developed for conditional protein inactivation. However, these methods require that either the protein of interest is first modified (Banaszynski et al., 2006, Caussinus et al., 2011, Neklesa et al., 2011, Nishimura et al., 2009, Robinson et al., 2010, Tachibana-Konwalski et al., 2010) or can only be applied to a very small number of proteins (Deshaies, 2015, Fan et al., 2014). Chemical inhibitors can be equally problematic as they are limited to druggable proteins and prone to off-target effects (Mayer, 2003). A widely applicable protein depletion method that acts exclusively at the protein level is currently lacking. Such a method would not only allow the acute depletion of endogenous proteins, but also the study of protein function in non-dividing primary cells in which DNA-targeting must be done at the whole animal level and RNA-targeting cannot deplete stable proteins. We sought to develop a truly posttranslational protein depletion method based on protein targeting by antibodies. Antibodies bind to proteins with high affinity and specificity; they are widely available commercially and can be produced for almost any protein with relative ease. Antibodies are therefore ideal as the basis of a protein-targeting method. Antibodies have been used previously to interfere with protein function (Morgan and Roth, 1988). However, this requires that the antibody binds to an epitope that blocks the function of a protein and can effectively and stoichiometrically compete with endogenous ligands. This method of inhibition is therefore only applicable to a very limited number of proteins. Instead, we aimed to develop a universally applicable method that would allow us to target any antibody-bound protein for degradation. Antibody-bound pathogens can be recognized by the cytosolic antibody receptor, TRIM21 (Mallery et al., 2010). TRIM21 is an E3 ubiquitin ligase that binds with high affinity to the Fc domain of antibodies (James et al., 2007). TRIM21 is widely expressed in diverse cell types and tissues, which is a necessary requirement of its physiological role (Yoshimi et al., 2009). During infection, TRIM21 recruits the ubiquitin-proteasome system to antibody-bound pathogens, leading to their destruction (Mallery et al., 2010). TRIM21 causes degradation of diverse pathogens including RNA and DNA viruses (Watkinson et al., 2015), bacteria (McEwan et al., 2013), and the proteopathic agent Tau (McEwan et al., 2017). Both the proteasome and the AAA ATPase VCP/p97 have been identified as important co-factors for degradation, but their requirement differs between substrates (Hauler et al., 2012). The E2 enzymes Ube2W and Ube2N/2V2 have also been implicated in TRIM21-mediated degradation (Fletcher et al., 2015). These enzymes act sequentially on TRIM21 itself, first mono-ubiquitinating it (Ube2W) and then extending from this a K63-ubiquitin chain (Ube2N/2V2). TRIM21 is also modified with K48-chains but the E2 enzyme(s) involved are unknown, as is the functional importance of this modification. TRIM21 has not been reported to modify the pathogen or the pathogen bound antibodies, but it is unclear if such modifications have escaped detection or if auto-ubiquitination of TRIM21 is sufficient for pathogen destruction. TRIM21 has also been reported to interact with several other proteins including Skp2, DAXX, IRF-3, IRF-5, IRF-8, DDX41, and SQSTM1 (James, 2014). However, most of these interactions have been detected based on immunoprecipitation, which can deliver false positives because of direct binding of TRIM21 to the antibodies used in the assay. In this study, we repurposed TRIM21 to establish a method to degrade endogenous proteins that we called Trim-Away. Trim-Away allows the study of protein function in various cell types, including non-dividing primary cells where genome- and RNA-targeting methods are not well suited. Trim-Away degrades proteins within minutes of application, making it suitable to investigate the function of a protein long after it has formed and at all stages of a cell’s life, cycle, or differentiation. Acute protein disruption assays, which in the past have required complex genetics and a lot of time, can now be done by Trim-Away within hours. Trim-Away therefore forms the basis for the systematic stage-specific analysis of protein function. RESULTS Principle of Protein Degradation by Trim-Away We reasoned that the antibody receptor and ubiquitin ligase TRIM21 could be used as a tool to drive the degradation of endogenous proteins by using a 3-step strategy: first, the introduction of exogenous TRIM21; second, the introduction of an antibody against the protein of interest; and third, TRIM21-mediated ubiquitination followed by degradation of the antibody-bound protein of interest (Figure 1A). As we outline in detail below, this strategy, which we called “Trim-Away,” is ideally suited for the acute and rapid degradation of endogenous proteins in both individual cells as well as bulk cell populations. [Figure: Acute Degradation of Proteins by Trim-Away(A) Schematic of Trim-Away approach.(B–E) NIH 3T3 cells overexpressing mCherry-TRIM21 (not shown) and free GFP (greys) were microinjected with anti-GFP antibody or control IgG (B and C) or treated with DMSO or MG132 and microinjected with anti-GFP antibody (D and E). Time shows minutes (min) from antibody microinjection; 0 min is just before antibody microinjection. Dashed